Home / Going-concern warnings / Outlook Therapeutics, Inc.
Filed 2026-05-15 路 Form 10-Q 路 Accession 0001104659-26-062632 nano
Price before filing: $0.2332 (2026-05-14 close, split/dividend-adjusted)
Market cap at flag: $18.7M (2026-05-15) 路 Latest: $12.4M (2026-10-16)
| Window | OTLK | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +397.4% | +0.9% | +396.5% | 2026-06-15 |
| 90 days | +281.1% | +4.2% | +276.9% | 2026-08-13 |
| 180 days | pending | pending | until 2026-11-11 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: no open-market insider sales or purchases reported.
30 days after: 5 insiders bought $5.3M (6 purchases)
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-05-15: red flag filed | |||||||
| 2026-05-26 | HILZINGER KURT J Director | Purchase | 400,000 | $0.44 | $177K | no | Form 4 |
| 2026-05-26 | Haddadin Yezan Munther Director | Purchase | 34,000 | $0.44 | $15K | no | Form 4 |
| 2026-05-26 | THURMAN RANDY H Director | Purchase | 5,000 | $0.43 | $2K | no | Form 4 |
| 2026-05-27 | Sukhtian Faisal Ghiath Director | Purchase | 122,174 | $0.41 | $50K | no | Form 4 |
| 2026-05-28 | Sukhtian Ghiath M. (+1 joint filer) Director, 10% owner | Purchase | 8,539,709 | $0.59 | $5.0M | no | Form 4 |
| 2026-06-02 | Haddadin Yezan Munther Director | Purchase | 29,000 | $0.83 | $24K | no | Form 4 |
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-02-14 to 2026-06-14. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"As a result, there is substantial doubt about the Company's ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2026-03-31)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.